Smith Hayes Advisers’s Pfizer PFE Stock Holding History

Smith Hayes Advisers’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$2.17M	Buy	77,234 +1,651	+2%	+$47.2K	0.44%	59
2015 Q4	$2.31M	Sell	75,583 -4,317	-5%	-$136K	0.49%	54
2015 Q3	$2.38M	Sell	79,900 -2,240	-3%	-$71.8K	0.52%	59
2015 Q2	$2.61M	Sell	82,140 -808	-1%	-$26.3K	0.52%	61
2015 Q1	$2.74M	Sell	82,948 -1,404	-2%	-$44.6K	0.54%	55
2014 Q4	$2.49M	Sell	84,352 -2,089	-2%	-$59.9K	0.52%	56
2014 Q3	$2.42M	Sell	86,441 -16,057	-16%	-$451K	0.57%	53
2014 Q2	$2.89M	Buy	102,498 +14,057	+16%	+$401K	0.68%	44
2014 Q1	$2.69M	Sell	88,441 -6,103	-6%	-$182K	0.67%	46
2013 Q4	$2.75M	Buy	94,544 +16,664	+21%	+$485K	0.9%	31
2013 Q3	$2.12M	Sell	77,880 -2,229	-3%	-$60.6K	0.81%	36
2013 Q2	$2.13M	Buy	+80,109	New	+$2.21M	0.88%	33

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Smith Hayes Advisers's PFE Position: Q1 2016 in Review

Smith Hayes Advisers increased its Pfizer (PFE) stake by 2.2% in Q1 2016, buying an estimated $47.2K and bringing the position to 77,234 shares worth $2.17M. The position accounts for 0.44% of the portfolio, ranked #59.

Smith Hayes Advisers first reported a position in PFE in Q2 2013 and has held it in 12 quarters since. The position peaked at $2.89M in Q2 2014. 1,967 funds tracked by Wall St. Rank hold PFE as of Q1 2016.

Smith Hayes Advisers held 77,234 shares of Pfizer worth $2.17M as of Q1 2016.
Smith Hayes Advisers bought 1,651 Pfizer shares in Q1 2016, an estimated $47.2K.
Pfizer made up 0.44% of Smith Hayes Advisers's portfolio in Q1 2016, its #59 holding.
Smith Hayes Advisers first reported a position in Pfizer in Q2 2013 and has held it in 12 quarters since.
Smith Hayes Advisers's Pfizer position peaked at $2.89M in Q2 2014.
1,967 funds tracked by Wall St. Rank held Pfizer as of Q1 2016.

Based on Smith Hayes Advisers's 13F filing for Q1 2016, filed 16 May 2016.